University of Cape Town
3 clinical trials · 3 recruiting · OTHER
Trials by University of Cape Town
RECRUITINGPhase 2 / Phase 3NCT04147286
Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
This is a proof-of-concept phase IIB, double-blind, randomized, placebo-controlled trial to evaluate the safety and efficacy of 40 mg atorvastatin to reduce persistent lung...
Sponsor: University of Cape TownEnrolling: 2201 location
Tuberculosis, Pulmonary
RECRUITINGPhase 2NCT04521803
High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
The investigators hypothesise that high dose RIF (RIF35) will increase pericardial fluid RIF exposure and so enhance mycobacterial clearance, compared to standard of care dosing...
Sponsor: University of Cape TownEnrolling: 602 locations
Tuberculous PericarditisHIV Status
RECRUITINGNCT06135818
Same Day Diagnosis of Extrapulmonary TB (TB Serositis and TB Meningitis).
Extrapulmonary TB (EPTB) accounts for nearly 30% of TB cases in HIV endemic settings, such as South Africa. The diagnosis of extrapulmonary TB is complicated by the poor...
Sponsor: University of Cape TownEnrolling: 21604 locations
Tuberculosis, Extrapulmonary